TY - JOUR
T1 - BAL cell gene expression in severe asthma reveals mechanisms of severe disease and influences of medications
AU - Weathington, Nathaniel
AU - O'Brien, Michael E.
AU - Radder, Josiah
AU - Whisenant, Thomas C.
AU - Bleecker, Eugene R.
AU - Busse, William W.
AU - Erzurum, Serpil C.
AU - Gaston, Benjamin
AU - Hastie, Annette T.
AU - Jarjour, Nizar N.
AU - Meyers, Deborah A.
AU - Milosevic, Jadranka
AU - Moore, Wendy C.
AU - Tedrow, John R.
AU - Trudeau, John B.
AU - Wong, Hesper P.
AU - Wu, Wei
AU - Kaminski, Naftali
AU - Wenzel, Sally E.
AU - Modena, Brian D.
N1 - Funding Information:
Supported by NIH/NHLBI grants HL109250, HL103453, HL69174, HL069116, HL69167, HL144888, HL126135, RC2 HL101487, CTSI UL1 RR024153, UL1 RR025011, 5 P01 AI106684-03, and K23 HL144418.
Publisher Copyright:
© 2019 by the American Thoracic Society.
PY - 2019/10/1
Y1 - 2019/10/1
N2 - Rationale: Gene expression ofBALcells,which samples the cellularmilieu within the lower respiratory tract, has not been well studied insevere asthma. Objectives: To identify new biomolecularmechanisms underlying severe asthma by an unbiased, detailed interrogation of global gene expression. Methods: BAL cell expression was profiled in 154 asthma and control subjects.Of these participants, 100 had accompanying airway epithelial cell gene expression. BAL cell expression profiles were related to participant (age, sex, race, and medication) and sample traits (cell proportions), and then severity-related gene expression determined by correlating transcripts and coexpression networks to lung function, emergency department visits or hospitalizations in the last year, medication use, and quality-of-life scores. Measurements and Main Results: Age, sex, race, cell proportions, and medications strongly influenced BAL cell gene expression, but leading severity-related genes could be determined by carefully identifying and accounting for these influences. A BAL cell expression network enriched for cAMPsignaling componentsmost differentiated subjects with severe asthma from other subjects. Subsequently, an in vitro cellularmodel showed this phenomenonwas likely caused by a robust upregulation in cAMP-related expression in nonsevere and β-agonist-naive subjects given a β-agonist before cell collection. Interestingly, ELISAs performed on BAL lysates showed protein levels may partly disagree with expression changes. Conclusions: Gene expression in BAL cells is influenced by factors seldomly considered.Notably,β-agonist exposure likely had a strong and immediate impact oncellular gene expression, whichmaynot translate to important disease mechanisms or necessarily match protein levels. Leading severity-related genes were discovered in an unbiased, systemwide analysis, revealing newtargets thatmapto asthma susceptibility loci.
AB - Rationale: Gene expression ofBALcells,which samples the cellularmilieu within the lower respiratory tract, has not been well studied insevere asthma. Objectives: To identify new biomolecularmechanisms underlying severe asthma by an unbiased, detailed interrogation of global gene expression. Methods: BAL cell expression was profiled in 154 asthma and control subjects.Of these participants, 100 had accompanying airway epithelial cell gene expression. BAL cell expression profiles were related to participant (age, sex, race, and medication) and sample traits (cell proportions), and then severity-related gene expression determined by correlating transcripts and coexpression networks to lung function, emergency department visits or hospitalizations in the last year, medication use, and quality-of-life scores. Measurements and Main Results: Age, sex, race, cell proportions, and medications strongly influenced BAL cell gene expression, but leading severity-related genes could be determined by carefully identifying and accounting for these influences. A BAL cell expression network enriched for cAMPsignaling componentsmost differentiated subjects with severe asthma from other subjects. Subsequently, an in vitro cellularmodel showed this phenomenonwas likely caused by a robust upregulation in cAMP-related expression in nonsevere and β-agonist-naive subjects given a β-agonist before cell collection. Interestingly, ELISAs performed on BAL lysates showed protein levels may partly disagree with expression changes. Conclusions: Gene expression in BAL cells is influenced by factors seldomly considered.Notably,β-agonist exposure likely had a strong and immediate impact oncellular gene expression, whichmaynot translate to important disease mechanisms or necessarily match protein levels. Leading severity-related genes were discovered in an unbiased, systemwide analysis, revealing newtargets thatmapto asthma susceptibility loci.
KW - Asthma
KW - Bronchoalveolar lavage
KW - Gene expression
KW - Genetics
KW - β-agonist
UR - http://www.scopus.com/inward/record.url?scp=85072747602&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072747602&partnerID=8YFLogxK
U2 - 10.1164/rccm.201811-2221OC
DO - 10.1164/rccm.201811-2221OC
M3 - Article
C2 - 31161938
AN - SCOPUS:85072747602
SN - 1073-449X
VL - 200
SP - 837
EP - 856
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
IS - 7
ER -